BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28732161)

  • 1. Elegant pH-Responsive Nanovehicle for Drug Delivery Based on Triazine Dendrimer Modified Magnetic Nanoparticles.
    Landarani-Isfahani A; Moghadam M; Mohammadi S; Royvaran M; Moshtael-Arani N; Rezaei S; Tangestaninejad S; Mirkhani V; Mohammadpoor-Baltork I
    Langmuir; 2017 Aug; 33(34):8503-8515. PubMed ID: 28732161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic triazine-based dendrimer as a versatile nanocarrier for efficient antiviral drugs delivery.
    Ahangarani-Farahani R; Bodaghifard MA; Asadbegi S
    Sci Rep; 2022 Nov; 12(1):19469. PubMed ID: 36376529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer medicines (Doxorubicin and methotrexate) conjugated with magnetic nanoparticles for targeting drug delivery through iron.
    Samra ZQ; Ahmad S; Javeid M; Dar N; Aslam MS; Gull I; Ahmad MM
    Prep Biochem Biotechnol; 2013; 43(8):781-97. PubMed ID: 23876138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery.
    Rasouli S; Davaran S; Rasouli F; Mahkam M; Salehi R
    Drug Deliv; 2014 May; 21(3):155-63. PubMed ID: 24107075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous dimer peptide-conjugated polylysine dendrimer-Fe
    Shen JM; Li XX; Fan LL; Zhou X; Han JM; Jia MK; Wu LF; Zhang XX; Chen J
    Int J Nanomedicine; 2017; 12():1183-1200. PubMed ID: 28243083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of pH-sensitive polyamino-ester magneto-dendrimers: Surface functional groups effect on viability of human prostate carcinoma cell lines DU145.
    Dayyani N; Khoee S; Ramazani A
    Eur J Med Chem; 2015 Jun; 98():190-202. PubMed ID: 26021708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic stimuli-responsive methotrexate-conjugated magnetic nanoparticles for target delivery to breast cancer cells and release study in lysosomal condition.
    Nosrati H; Mojtahedi A; Danafar H; Kheiri Manjili H
    J Biomed Mater Res A; 2018 Jun; 106(6):1646-1654. PubMed ID: 29441671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells.
    Nosrati H; Adibtabar M; Sharafi A; Danafar H; Hamidreza Kheiri M
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1377-1384. PubMed ID: 29560737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies.
    Rastegari B; Karbalaei-Heidari HR; Zeinali S; Sheardown H
    Colloids Surf B Biointerfaces; 2017 Oct; 158():589-601. PubMed ID: 28750341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
    ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and Evaluation of pH Sensitive Novel Anticancer Drug Carrier Based on Magnetic Chitosan Quartets.
    Danafar H; Asadi F; Sharafi A; Manjili HK
    Drug Res (Stuttg); 2019 Sep; 69(9):496-504. PubMed ID: 30912092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendrimer functionalized magnetic nanoparticles as a promising platform for localized hyperthermia and magnetic resonance imaging diagnosis.
    Esmaeili E; Khalili M; Sohi AN; Hosseinzadeh S; Taheri B; Soleimani M
    J Cell Physiol; 2019 Aug; 234(8):12615-12624. PubMed ID: 30536886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple preparation of maltose-functionalized dendrimer/graphene quantum dots as a pH-sensitive biocompatible carrier for targeted delivery of doxorubicin.
    Karimi S; Namazi H
    Int J Biol Macromol; 2020 Aug; 156():648-659. PubMed ID: 32289413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate anticancer drug delivery to breast cancer cell lines by iron oxide magnetic based nanocarrier.
    Attari E; Nosrati H; Danafar H; Kheiri Manjili H
    J Biomed Mater Res A; 2019 Nov; 107(11):2492-2500. PubMed ID: 31298774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucosamine-Modified Mesoporous Silica-Coated Magnetic Nanoparticles: A "Raisin-Cake"-like Structure as an Efficient Theranostic Platform for Targeted Methotrexate Delivery.
    Farjadian F; Faghih Z; Fakhimi M; Iranpour P; Mohammadi-Samani S; Doroudian M
    Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of novel superparamagnetic Ni
    Qasim M; Asghar K; Dharmapuri G; Das D
    Nanotechnology; 2017 Sep; 28(36):365101. PubMed ID: 28675377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTX-Loaded Dual Thermoresponsive and pH-Responsive Magnetic Hydrogel Nanocomposite Particles for Combined Controlled Drug Delivery and Hyperthermia Therapy of Cancer.
    Najafipour A; Gharieh A; Fassihi A; Sadeghi-Aliabadi H; Mahdavian AR
    Mol Pharm; 2021 Jan; 18(1):275-284. PubMed ID: 33300343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.
    Ebadi M; Bullo S; Buskara K; Hussein MZ; Fakurazi S; Pastorin G
    Sci Rep; 2020 Dec; 10(1):21521. PubMed ID: 33298980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Smart Magnetically Active Nanovehicle for on-Demand Targeted Drug Delivery: Where van der Waals Force Balances the Magnetic Interaction.
    Panja S; Maji S; Maiti TK; Chattopadhyay S
    ACS Appl Mater Interfaces; 2015 Nov; 7(43):24229-41. PubMed ID: 26458134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system.
    Barahuie F; Dorniani D; Saifullah B; Gothai S; Hussein MZ; Pandurangan AK; Arulselvan P; Norhaizan ME
    Int J Nanomedicine; 2017; 12():2361-2372. PubMed ID: 28392693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.